| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.008 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.008 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |